Quantamental Technologies LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 151 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Quantamental Technologies LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$44,000
+4.8%
9,424
-6.0%
0.02%
-20.0%
Q4 2018$42,00010,0240.02%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2019.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders